These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase. Luo Z, Yu L, Yang F, Zhao Z, Yu B, Lai H, Wong KH, Ngai SM, Zheng W, Chen T. Metallomics; 2014 Aug; 6(8):1480-90. PubMed ID: 24823440 [Abstract] [Full Text] [Related]
6. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells. Du Y, Fu X, Li H, Chen B, Guo Y, Su G, Zhang H, Ning F, Lin Y, Mei W, Chen T. ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015 [Abstract] [Full Text] [Related]
8. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. Brabec V, Nováková O. Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363 [Abstract] [Full Text] [Related]
13. Synthesis, antitumor activity and structure-activity relationships of a series of Ru(II) complexes. Liu J, Zheng W, Shi S, Tan C, Chen J, Zheng K, Ji L. J Inorg Biochem; 2008 Feb; 102(2):193-202. PubMed ID: 17825915 [Abstract] [Full Text] [Related]